Pharmacy

The unique system-generated identifier assigned to a drug record within the pharmacy or clinical data system. Enables consistent tracking and cross-referencing of a specific drug across pharmacy benefit management, claims processing, and clinical data warehouse environments.

A reference identifier pointing to the intended biological target, formulary tier, patient population, or therapeutic goal associated with a drug record in EHR and PBM systems. Used in clinical decision support, precision medicine pipelines, and formulary design analytics to align drug assignments with treatment protocols.

A classification code that categorizes a drug into a standardized therapeutic or pharmacological hierarchy, such as GPI or drug class groupings. Used in pharmacy benefit management and formulary systems to organize drugs by therapeutic category for clinical and administrative reporting.

The required storage or handling temperature specification for a drug or pharmaceutical compound, such as refrigerated or room temperature requirements. Critical in pharmacy and specialty drug management to ensure proper storage, handling, and distribution conditions are maintained.

The date on which a drug record, formulary listing, or drug coverage designation becomes inactive or expires. Used in pharmacy benefit management and formulary administration to control drug eligibility periods and ensure accurate claims adjudication and coverage determinations.

A medication within the same therapeutic class as a prescribed drug that produces similar clinical outcomes and can be substituted based on clinical criteria, formulary status, and cost-effectiveness, distinct from a generic equivalent which contains the same active ingredient. Therapeutic alternatives are used in step therapy protocols and formulary management to direct prescribing toward preferred agents within a therapeutic category.

The time-of-day value associated with drug administration, dispensing, or transaction recording in EHR, pharmacy, and PBM systems. Used in medication administration records, inpatient nursing workflows, and timestamp-based analytics to support chronological event sequencing and drug-drug interaction timing assessments.

A system-generated datetime value recording when a drug transaction was created, updated, or processed within pharmacy and PBM platforms. Used for audit logging, change data capture in ETL pipelines, adjudication sequencing, and reconciliation of drug records across EHR, claims, and dispensing system integrations.

The formal name or label assigned to a pharmaceutical compound, which may include brand name, generic name, or a descriptive designation used in formulary and pharmacy systems. Supports drug identification, formulary display, member communications, and pharmacy benefit reporting.

The aggregated sum value of a drug-related metric such as quantity dispensed, cost, days supply, or claim count within pharmacy, PBM, and claims systems. Used in utilization reporting, rebate calculations, formulary spend analytics, and financial reconciliation across payer and pharmacy benefit management platforms.

The aggregate count of drug records, prescriptions, or occurrences within a defined data set or reporting period. Used in pharmacy analytics and benefit management reporting to measure drug utilization volumes, formulary compliance, and prescription trend analysis.

A categorical classification identifying the nature of a pharmaceutical compound, such as brand, generic, specialty, biologic, or OTC, within pharmacy, PBM, and formulary management systems. Used to drive formulary tier placement, cost-sharing logic, prior authorization rules, and drug utilization reporting in claims pipelines.

The standardized unit of measure associated with a drug quantity, such as tablet, milliliter, gram, or unit dose, in pharmacy, EHR, and PBM systems. Used to normalize dispensing quantities across NDC records, support days-supply calculations, enable cross-system drug comparisons, and validate claim-level quantity fields.

The most recent date on which a drug record was modified in the pharmacy or clinical data system, including changes to drug attributes, formulary status, or pricing. Used for data governance, audit trail tracking, and ensuring current drug information is applied in claims adjudication.

A classification indicating the time-sensitivity or clinical priority level associated with dispensing or administering a specific drug, such as urgent, emergent, or routine. Used in pharmacy workflow and specialty drug management to prioritize fulfillment and ensure clinically appropriate dispensing timelines.

A program evaluating prescription drug use to identify and prevent drug-related problems including therapeutic duplication, drug-drug interactions, drug-disease contraindications, incorrect dosing, and abuse or misuse patterns, conducted prospectively at the point of dispensing or retrospectively through claims analysis. Drug utilization review is required for Medicaid pharmacy programs under OBRA 90 and is implemented by pharmacy benefit managers through clinical edits during claims adjudication.

A real-time clinical alert generated during pharmacy claims adjudication identifying a potential drug-related problem requiring pharmacist review before dispensing, including drug-drug interaction warnings, drug-disease contraindications, duplicate therapy alerts, high dose warnings, and age-related dosing concerns. DUR alerts are generated by clinical decision support software integrated into pharmacy dispensing systems and must be reviewed by the dispensing pharmacist.

A measured data attribute representing a therapeutic chemical compound's quantitative or qualitative property stored in pharmacy, PBM, or EHR systems. Used in drug master files and formulary databases to support clinical decision support, pricing logic, and drug classification workflows.

A sequential version number assigned to a drug record to track revisions made over time within the pharmacy or formulary management system. Supports data lineage, audit compliance, and ensures the most current drug attributes are applied during claims adjudication and formulary evaluation.

The unused portion of a single-use vial, prefilled syringe, or other drug packaging discarded after partial use for a patient dose, representing a significant cost issue for injectable and infusional specialty drugs. Drug waste costs are billed by providers and covered by health plans for certain infusional drugs administered in physician offices and infusion centers, with site-of-care management programs reducing waste costs by directing infusions to more cost-efficient settings.